Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Clinical Success Rate
    100.0%

    Based on 1 completed trials

    Completion Rate
    100%(1/1)
    Active Trials
    1(50%)
    Results Posted
    100%(1 trials)

    Phase Distribution

    Not Applicable
    1
    50%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    0

    Late Stage

    Phase Distribution1 total trials
    N/ANon-phased studies
    1(100.0%)

    Highest Phase Reached

    Unknown

    Trial Status & Enrollment

    Completion Rate

    100.0%

    1 of 1 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Completed(1)

    Detailed Status

    Recruiting1
    Completed1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    100.0%
    Most Advanced
    N/A

    Trials by Phase

    N/A1 (100.0%)

    Trials by Status

    recruiting150%
    completed150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    recruiting

    North American Comfilcon A Clinical Study

    NCT06902584
    completednot_applicable

    Comparison of Comfilcon A Toric Contact Lenses and Samfilcon A Toric Contact Lenses

    NCT03519932

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT06902584

    North American Comfilcon A Clinical Study

    Recruiting
    NCT03519932Not Applicable

    Comparison of Comfilcon A Toric Contact Lenses and Samfilcon A Toric Contact Lenses

    Completed

    All 2 trials loaded

    Drug Details

    Intervention Type
    Device
    Total Trials
    2